Spotlight on Thoma Bravo’s Circle CVI deal; vote of confidence for Vista

Thoma Bravo's investment in Circle Cardiovascular Imaging goes under the microscope.

25 March 2022•4 mins read

[data-article-body-skeleton]{display:none!important}

JavaScript is required to read this article. Please enable it in your browser and reload the page.